Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study von Walker, Joan L, Brady, Mark F, Wenzel, Lari, Fleming, Gini F, Huang, Helen Q, DiSilvestro, Paul A, Fujiwara, Keiichi, Alberts, David S, Zheng, Wenxin, Tewari, Krishnansu S, Cohn, David E, Powell, Matthew A, Van Le, Linda, Davidson, Susan A, Gray, Heidi J, Rose, Peter G, Aghajanian, Carol, Myers, Tashanna, Alvarez Secord, Angeles, Rubin, Stephen C, Mannel, Robert S

Volltext

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0... von Coleman, Robert L, Prof, Brady, Mark F, Prof, Herzog, Thomas J, Prof, Sabbatini, Paul, Prof, Armstrong, Deborah K, Prof, Walker, Joan L, Prof, Kim, Byoung-Gie, Prof, Fujiwara, Keiichi, Prof, Tewari, Krishnansu S, Prof, O'Malley, David M, Prof, Davidson, Susan A, MD, Rubin, Stephen C, Prof, DiSilvestro, Paul, Prof, Basen-Engquist, Karen, Prof, Huang, Helen, MS, Chan, John K, MD, Spirtos, Nick M, MD, Ashfaq, Raheela, MD, Mannel, Robert S, MD

Volltext

Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary periton... von Behbakht, Kian, Sill, Michael W, Darcy, Kathleen M, Rubin, Stephen C, Mannel, Robert S, Waggoner, Steven, Schilder, Russell J, Cai, Kathy Q, Godwin, Andrew K, Alpaugh, R. Katherine

Volltext

Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study von WINTER, William E, MAXWELL, G. Larry, CHUNQIAO TIAN, SUNDBORG, Michael J, ROSE, G. Scott, ROSE, Peter G, RUBIN, Stephen C, MUGGIA, Franco, MCGUIRE, William P

Volltext

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study von BURGER, Robert A, BRADY, Mark F, LIM, Peter C, RUBIN, Stephen C, KATSUMATA, Noriyuki, LIANG, Sharon X, BOOKMAN, Michael A, MONK, Bradley J, WALKER, Joan L, HOMESLEY, Howard D, FOWLER, Jeffrey, GREER, Benjamin E, BOENTE, Matthew, FLEMING, Gini F

Volltext

Phase II trial of weekly paclitaxel (80 mg/m 2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study von Markman, Maurie, Blessing, John, Rubin, Stephen C., Connor, Joseph, Hanjani, Parviz, Waggoner, Steven

Volltext

Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma von Rose, Peter G, Nerenstone, Stacy, Brady, Mark F, Clarke-Pearson, Daniel, Olt, George, Rubin, Stephen C, Moore, David H, Small, James M

Volltext

Vascular leukocytes contribute to tumor vascularization von Conejo-Garcia, Jose R., Buckanovich, Ronald J., Benencia, Fabian, Courreges, Maria C., Rubin, Stephen C., Carroll, Richard G., Coukos, George

Volltext

Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study von DEMICHELE, Angela, TROXEL, Andrea B, REBBECK, Timothy R, STROM, Brian L, BERLIN, Jesse A, WEBER, Anita L, BUNIN, Greta R, TURZO, Elene, SCHINNAR, Rita, BURGH, Desiree, BERLIN, Michelle, RUBIN, Stephen C

Volltext

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer von Chan, John K, Brady, Mark F, Penson, Richard T, Huang, Helen, Birrer, Michael J, Walker, Joan L, DiSilvestro, Paul A, Rubin, Stephen C, Martin, Lainie P, Davidson, Susan A, Huh, Warner K, O’Malley, David M, Boente, Matthew P, Michael, Helen, Monk, Bradley J

Volltext

Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With BRCA1/2 Mutations: A Decision Analysis von ARMSTRONG, Katrina, SCHWARTZ, J. Sanford, RANDALL, Thomas, RUBIN, Stephen C, WEBER, Barbara

Volltext

A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study von Aghajanian, Carol, Blessing, John A, Darcy, Kathleen M, Reid, Gary, DeGeest, Koen, Rubin, Stephen C, Mannel, Robert S, Rotmensch, Jacob, Schilder, Russell J, Riordan, William

Volltext

A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis von HAHN, Stephen M, FRAKER, Douglas L, PUTT, Mary, RUBIN, Stephen C, MENON, Chandrakala, WANG, Hsing-Wen, SHIN, Daniel, YODH, Arjun, GLATSTEIN, Eli, MICK, Rosemarie, METZ, James, BUSCH, Theresa M, SMITH, Debbie, ZHU, Timothy, RODRIGUEZ, Carmen, DIMOFTE, Andreea, SPITZ, Francis

Volltext

Clinical predictors of bevacizumab-associated gastrointestinal perforation von Tanyi, Janos L, McCann, Georgia, Hagemann, Andrea R, Coukos, George, Rubin, Stephen C, Liao, John B, Chu, Christina S

Volltext

Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: A clinically recalcitrant entity von Liao, John B, Jean, Stephanie, Wilkinson-Ryan, Ivy, Ford, Ashley E, Tanyi, Janos L, Hagemann, Andrea R, Lin, Lilie L, McGrath, Cindy M, Rubin, Stephen C

Volltext

Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer von Zhang, Lin, Conejo-Garcia, Jose R, Katsaros, Dionyssios, Gimotty, Phyllis A, Massobrio, Marco, Regnani, Giorgia, Makrigiannakis, Antonis, Gray, Heidi, Schlienger, Katia, Liebman, Michael N, Rubin, Stephen C, Coukos, George

Volltext

Primary lymphomas of the cervix and uterus: The University of Pennsylvania's experience and a review of the literature von Frey, Noelle V., Svoboda, Jakub, Andreadis, Charalambos, Tsai, Donald E., Schuster, Stephen J., Elstrom, Rebecca, Rubin, Stephen C., Nasta, Sunita D.

Volltext

Group‐based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancers von Manne, Sharon L., Myers‐Virtue, Shannon, Kissane, David, Ozga, Melissa L., Kashy, Deborah A., Rubin, Stephen C., Rosenblum, Norman G., Heckman, Carolyn J.

Volltext

TRANCE- and CD40 Ligand-matured Dendritic Cells Reveal MHC Class I-restricted T Cells Specific for Autologous Tumor in Late-Stage Ovarian Cancer Patients von SCHLIENGER, Katia, CHU, Christina S, KAISER, Larry R, RUBIN, Stephen C, LEVINE, Bruce L, CARROLL, Richard G, JUNE, Carl H, WOO, Edward Y, RIVERS, Patricia M, TOLL, Alanna J, HUDSON, Brian, MAUS, Marcela V, RILEY, James L, CHOI, Yongwon, COUKOS, George

Volltext

Intraepithelial T Cells and Tumor Proliferation: Impact on the Benefit From Surgical Cytoreduction in Advanced Serous Ovarian Cancer von ADAMS, Sarah F, LEVINE, Douglas A, CADUNGOG, Mark G, HAMMOND, Rachel, FACCIABENE, Andrea, OLVERA, Narciso, RUBIN, Stephen C, BOYD, Jeff, GIMOTTY, Phyllis A, COUKOS, George

Volltext